Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma
Open Access
- 3 March 2023
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2023, 1-29
Abstract
Background. Necroptosis is progressively becoming an important focus of research because of its role in the pathogenesis of cancer and other inflammatory diseases. Our study is designed to anticipate the survival time of kidney renal clear cell carcinoma (KIRC) by constructing a prognostic signature of necroptosis-related genes. Materials. Clinical information and RNA-seq data were acquired from Renal Cell Cancer-European Union (RECA-EU) and The Cancer Genome Atlas- (TCGA-) KIRC, respectively. ConsensusClusterPlus was used to identify molecular subtypes, and the distribution of immune cell infiltration, anticancer drug sensitivity, and somatic gene mutations was studied in these subtypes. Subsequently, LASSO-Cox regression and univariate Cox regression were also carried out to construct a necroptosis-related signature. Cox regression, survival analysis, clinicopathological characteristic correlation analysis, nomogram, cancer stem cell analysis, and receiver operating characteristic (ROC) curve were some tools employed to study the prognostic power of the signature. Results. Based on the expression patterns of 66 survival-related necroptosis genes, we classified the KIRC into three subtypes (C1, C2, and C3) that are associated with necroptosis, which had significantly different tumor stem cell components. Among these, C2 patients had a longer survival time and enhanced immune status and were more sensitive to conventional chemotherapeutic drugs. Moreover, in order to predict the prognosis of KIRC patients, five genes (BMP8A, TLCD1, CLGN, GDF7, and RARB) were used to develop a necroptosis-related prognostic signature, which had an acceptable predictive potency. The results from Cox regression and stratified survival analysis revealed that the signature was an independent prognostic factor, whereas the nomogram and calibration curve demonstrated satisfactory survival time prediction based on the risk score. Conclusions. Three molecular subtypes and five necroptosis-related genes were discovered in KIRC using data from TCGA-KIRC and RECA-EU. Thus, a new biomarker and a potentially effective therapeutic approach for KIRC patients were provided in the current study.Keywords
Funding Information
- Health Commission of Hunan Province (202104101985, 202150064015, 2020YB-XJG127, 2020JJ4539, 2021JJ30610)
- Science and Technology Innovation Project of Hengyang City (202104101985, 202150064015, 2020YB-XJG127, 2020JJ4539, 2021JJ30610)
- University of South China (202104101985, 202150064015, 2020YB-XJG127, 2020JJ4539, 2021JJ30610)
- Natural Science Foundation of Hunan Province (202104101985, 202150064015, 2020YB-XJG127, 2020JJ4539, 2021JJ30610)
This publication has 36 references indexed in Scilit:
- Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeuticsCell Research, 2015
- Necroptosis and its role in inflammationNature, 2015
- Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancerNeoplasma, 2015
- pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression LevelsPLOS ONE, 2014
- NecroptosisNew England Journal of Medicine, 2014
- Application of ggplot2 to Pharmacometric GraphicsCPT: Pharmacometrics & Systems Pharmacology, 2013
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-αCell, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular targetProceedings of the National Academy of Sciences, 2006